1
Moderna's mRNA flu shot earns FDA approval after rollercoaster review
Moderna mRNA流感疫苗获批，老年人群迎来新选择，技术路线再获验证。
Moderna's new flu vaccine, mFLUSIVA, is approved for all adults ages 50 and up.
2
Moderna gets $50 million to develop mRNA Ebola vaccine against Bundibugyo
Moderna获超5000万美元资助，加速开发mRNA埃博拉疫苗应对刚果（金）疫情
Amid a raging Ebola outbreak, officials "urgently accelerate development" of vaccines.
3
Accelerating the development of life-saving treatments
OpenAI与Moderna合作，AI加速药物研发流程，展现AI在医疗领域的巨大潜力。
Accelerating the development of life-saving treatments.